LivaNova Announces the Launch of the PLATINIUM ICD & CRT-D Family Providing the World’s Longest Projected Longevity

PLATINIUM, released simultaneously in both Europe and Japan by LivaNova (formerly Sorin Group), will protect patients from avoidable replacement surgeries and the inherent risk of complications

LONDON.,  LivaNova PLC, a leading global medical technology company, is proud to announce the commercial launch of PLATINIUM, a new range of implantable cardiac defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-Ds*).

PLATINIUM offers unmatched longevity¹ thanks to a breakthrough technology that ensures extremely low electrical intrinsic consumption. In standard functioning conditions, the service life is projected to last over 14 years for the single-chamber ICD model, over 13 years for the dual-chamber ICD model, and over 10 years for CRT-D devices.

More than 60% of patients are under 70 years of age at the time of their first implant, and more than one third will require at least one replacement due to battery depletion. Replacement procedures are associated with twice as many surgical re-interventions as compared to de-novo procedures due to increased rates of complications, such as infections. The mortality rate in patients with an infection reaches 16.9% at 1 Year and 27.5% at 3 Years.

The outstanding longevity of PLATINIUM aims to limit the number of device replacements, minimizing the risks that are inherent in replacement surgeries.

The industry-leading longevity of PLATINIUM has been achieved without compromising the size of the device. PLATINIUM’s size ranges from 31cc to 33cc, and the Ergoform^TM design of the can, with its rounded shape and smooth edges was designed to facilitate the implant procedure and improve patient comfort.

PLATINIUM devices also feature proven therapeutic functions such as PARAD+^TM, a best-in-class arrhythmia discrimination algorithm, SafeR^TM, a pacing mode which preserves natural heart conduction and SonR^TM, the only hemodynamic sensor which automatically optimizes CRT settings.

“It’s clear that there is a growing mismatch between patient life expectancy and the longevity of ICD and CRT-D devices”, said Dr Philippe Ritter, M.D., Hôpital Cardiologique du Haut Levêque,University of Bordeaux, France. “This leads to a very high rate of replacement which can generate major complications for patients and significant associated costs. This is a serious issue for patients and PLATINIUM, with an expected service life of over 14 years, addresses this gap.”

“With PLATINIUM we are definitively entering a new era for ICD and CRT-D devices. PLATINIUM’s unsurpassed longevity¹will benefit all patients, both those who, thanks to the efforts of the medical community, are living longer as well as those who are receiving their first device at a younger age”, said Stefano Di Lullo, LivaNova, President of the CRM Business Unit. “PLATINIUM’s outstanding longevity together with its small size and proven therapeutic features reflect our commitment to developing breakthrough technologies that provide the very best care to patients”.

Source: LinaNova